Novartis submits meningitis B drug for U.S. approval

ZURICH Tue Jun 17, 2014 1:43am EDT

A Novartis logo is pictured on its headquarters building in Mumbai February 6, 2014. REUTERS/Danish Siddiqui

A Novartis logo is pictured on its headquarters building in Mumbai February 6, 2014.

Credit: Reuters/Danish Siddiqui

Related Topics

ZURICH (Reuters) - Swiss drugmaker Novartis said on Tuesday it had submitted its meningitis B vaccine Bexsero for adolescents and young people to the U.S. Food and Drug Administration (FDA) for marketing approval.

Bexsero, a broad coverage vaccine to help protect against meningitis B, is already approved in 34 countries including across the European Union, Canada and Australia, Novartis said.

Novartis has already provided nearly 30,000 doses of Bexsero to students and staff at Princeton University and the University of California Santa Barbara after meningitis B outbreaks on their campuses, the drugmaker said.

(Reporting by Alice Baghdjian)

FILED UNDER:
We welcome comments that advance the story through relevant opinion, anecdotes, links and data. If you see a comment that you believe is irrelevant or inappropriate, you can flag it to our editors by using the report abuse links. Views expressed in the comments do not represent those of Reuters. For more information on our comment policy, see http://blogs.reuters.com/fulldisclosure/2010/09/27/toward-a-more-thoughtful-conversation-on-stories/
Comments (1)
MUSAorg wrote:
The Meningitis Foundation of America offers extensive information regarding diagnosis, immunization, recovery and the after effects of meningitis. MFA survives primarily by donations. For the past 16 years, we have assisted people through support groups, resources and advocacy in efforts to help those affected with meningitis overcome and those around them understand the journey ahead. We promote prevention and safety measure in at risk communities and help explain the short term, long term effects and recovery treatments of meningitis to the media and public at large. Meningitis is a dangerous & often times fatal infection that can lead to serious life-long physical problems and even death. We are here to provide emotional support to those who need it; please feel free to reach out to us at www.musa.org.
Caroline L. Petrie
National Secretary
Meningitis Foundation of America, Inc.
World Meningitis Day 24 April
Educate~Vaccinate~Eradicate

Jun 17, 2014 11:07pm EDT  --  Report as abuse
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.

Pictures